Cited by 114Cardiac pacing and defibrillation studiesTelemedicine and Telehealth ImplementationECG Monitoring and Analysis

Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogations in Clinic: Results from a Randomized Pilot Clinical Trial

AL‐KHATIB, SANA M., PICCINI, JONATHAN P., KNIGHT, DAVID, STEWART, MARGARET, CLAPP‐CHANNING, NANCY, SANDERS, GILLIAN D.·2010·Journal of Cardiovascular Electrophysiology

Abstract

ICD: Remote Monitoring Versus Clinic Interrogations. Introduction:Remote monitoring is increasingly becoming the new standard of care for implantable cardioverter defibrillator (ICD) follow‐up. We sought to determine whether remote monitoring of ICDs improves patient outcomes compared with quarterly device interrogations in clinic. Methods and Results:In this single‐center pilot clinical trial, adult patients with an ICD were randomly assigned to remote monitoring versus quarterly device interrogations in clinic. The primary endpoint was a composite of cardiovascular hospitalization, emergency room visit for a cardiac cause, and unscheduled visit to the electrophysiology clinic for a device‐related issue at 1 year. We also examined health‐related quality of life, costs, and patient satisfaction with their ICD care. Of 151 patients enrolled in this trial, 76 were randomized to remote monitoring and 75 to quarterly device interrogations in clinic. There was no significant difference in the primary endpoint (32% in the remote monitoring arm vs 34% in the control arm; P = 0.8), mortality, or cost between the 2 arms. Quality of life and patient satisfaction were significantly better in the control arm than in the remote monitoring arm at 6 months (83 [25th, 75th percentiles 70, 90] vs 75 [50, 85]; P = 0.002 and 88 [75, 100] vs 75 [75, 88]; P = 0.03, respectively), but not at 12 months. Conclusion:We showed no significant reduction in cardiac‐related resource utilization with remote monitoring of ICDs. However, given the small number of patients in our study, the real clinical and health economics impact of remote monitoring needs to be verified by a large, multicenter, randomized clinical trial.(J Cardiovasc Electrophysiol, Vol. 21, pp. 545‐550, May 2010)

Integrity signals

Registry

Crossref · 10.1111/j.1540-8167.2009.01659.x

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
AL‐KHATIB, S. M., PICCINI, J. P., KNIGHT, D., STEWART, M., CLAPP‐CHANNING, N., & SANDERS, G. D.
Affiliations
  • Duke Medical Center (US)
  • Duke Clinical Research Institute (US)
Venue
Journal of Cardiovascular Electrophysiology
Publisher
Wiley
Published
2010-04-15
Volume
21
Issue
5
Pages
545-550
ISSN
  • 1045-3873 (ISSN-L)
  • 1540-8167
OpenAlex
W2086481724
Cited by
114
References
18
Citations by year
2025: 3 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 11 · 2015: 8 · 2014: 12 · 2013: 16 · 2012: 9
FWCI
4.53
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Cardiovascular Electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
Keywords
implantable cardioverter-defibrillator, remote monitoring, device interrogation, ICD follow-up, health-related quality of life, patient satisfaction, health care costs, resource utilization (health care), cardiovascular hospitalization, emergency department visits
MeSH terms
Aged, Anti-Arrhythmia Agents, Arrhythmias, Cardiac, Cost-Benefit Analysis, Cost Control, Female, Humans, Male, Middle Aged, Monitoring, Physiologic, Office Visits, Pilot Projects, Quality of Life, Telephone, Treatment Outcome, Patient Satisfaction, Defibrillators, Implantable, Endpoint Determination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review